The inherent limitations of traditional drying processes like freeze drying/lyophilization and conventional spray drying methods make it difficult for manufacturers to adopt these processes for making biotherapeutics, pharmaceuticals, probiotics and other biologics, battery energy storage, food and beverage, cosmetics, and other high-value powders. Those processes can produce too little powder, too slowly, or can cause loss of active compounds. They can be costly, involve designing of complex cycles, and/or difficult to scale, thus delaying sales and profitability. Sometimes, these current drying technologies may not be compatible with the new innovative drugs and materials that are in the discovery phase. Fluid Air helps our customers avoid or overcome those challenges and get to market faster with lower cost and investment. How do we do it? With powder production processes and equipment that are ideal for making biologics and other high-value powders, from lab-scale to production-scale. Our most advanced production system, PolarDry patented drying technology, is our proudest innovation. It is a system for making product with high quality, high efficiency, and reliable throughput. In many cases, post-processing, such as particle size reduction, is minimized or eliminated with PolarDry. However, if needed, we have a product line of fluid bed systems, high shear granulators, particle size reduction systems, bin and bowl elevators, tablet coating optimization systems, and process control software. Fluid Air Naperville houses extensively equipped labs and is staffed with scientists and engineers, which provides us with the ability to test and prove processes using PolarDry. This can bring greater success, months faster and with less risk. Fluid Air, founded in 1983, is a division of Spraying Systems Co., the world leader in spray nozzle technology.